melanocortin based peptide pt141. COM Jan. 2008 Diagnosis benign penile melanotic macules Clinical

Location on the palate increases the rate of suspicion of melanoma and usually requires a biopsy

Intended Use: Strictly for in-vitro laboratory research

This difference in selectivity makes PT-141 a more precise tool for studying MC4R signaling in CNS models, while MT-II is applicable in studies also involving the pigmentation pathway

Possible Side Effects PT-141 (Bremelanotide) is generally well-tolerated in clinical and preclinical research settings, though several transient effects have been documented

When Mori or Pacific peoples do present with melanoma they often have thicker lesions and more extensive disease at diagnosis